206 related articles for article (PubMed ID: 25139552)
1. A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention.
Morata L; Senneville E; Bernard L; Nguyen S; Buzelé R; Druon J; Tornero E; Mensa J; Soriano A
Infect Dis Ther; 2014 Dec; 3(2):235-43. PubMed ID: 25139552
[TBL] [Abstract][Full Text] [Related]
2. Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention.
Tornero E; Morata L; Martínez-Pastor JC; Angulo S; Combalia A; Bori G; García-Ramiro S; Bosch J; Mensa J; Soriano A
J Antimicrob Chemother; 2016 May; 71(5):1395-401. PubMed ID: 26929270
[TBL] [Abstract][Full Text] [Related]
3. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study.
Rodríguez-Pardo D; Pigrau C; Lora-Tamayo J; Soriano A; del Toro MD; Cobo J; Palomino J; Euba G; Riera M; Sánchez-Somolinos M; Benito N; Fernández-Sampedro M; Sorli L; Guio L; Iribarren JA; Baraia-Etxaburu JM; Ramos A; Bahamonde A; Flores-Sánchez X; Corona PS; Ariza J;
Clin Microbiol Infect; 2014 Nov; 20(11):O911-9. PubMed ID: 24766536
[TBL] [Abstract][Full Text] [Related]
4. Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to
Becker A; Kreitmann L; Triffaut-Fillit C; Valour F; Mabrut E; Forestier E; Lesens O; Cazorla C; Descamps S; Boyer B; Chidiac C; Lustig S; Montbarbon E; Batailler C; Ferry T
J Bone Jt Infect; 2020; 5(1):28-34. PubMed ID: 32117687
[No Abstract] [Full Text] [Related]
5. Debridement, antibiotics and implant retention (DAIR): An effective treatment option for early prosthetic joint infections.
Tatarelli P; Romani T; Santoro V; Spezia M; Gallo A; Ripamonti G; Carducci M; Trotti C; Parisini A; Nicolini LA; Mikulska M; Borrè S; Bassetti M
J Infect Chemother; 2021 Aug; 27(8):1162-1168. PubMed ID: 33781690
[TBL] [Abstract][Full Text] [Related]
6. Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis.
Martínez-Pastor JC; Muñoz-Mahamud E; Vilchez F; García-Ramiro S; Bori G; Sierra J; Martínez JA; Font L; Mensa J; Soriano A
Antimicrob Agents Chemother; 2009 Nov; 53(11):4772-7. PubMed ID: 19687237
[TBL] [Abstract][Full Text] [Related]
7. The Role of Long-Term Antibiotic Suppression in the Management of Peri-Prosthetic Joint Infections Treated With Debridement, Antibiotics, and Implant Retention: A Systematic Review.
Malahias MA; Gu A; Harris EC; Adriani M; Miller AO; Westrich GH; Sculco PK
J Arthroplasty; 2020 Apr; 35(4):1154-1160. PubMed ID: 31955984
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management-A multicenter retrospective study.
Mahieu R; Dubée V; Seegers V; Lemarié C; Ansart S; Bernard L; Le Moal G; Asseray N; Arvieux C; Ramanantsoa C; Cormier H; Legrand E; Abgueguen P;
Int J Infect Dis; 2019 Aug; 85():175-181. PubMed ID: 31212103
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis.
Yusuf E; Bramer W; Anas AA
Int J Antimicrob Agents; 2024 Jan; 63(1):107015. PubMed ID: 37875179
[TBL] [Abstract][Full Text] [Related]
10. Does a New Antibiotic Scheme Improve the Outcome of
Auñón Á; Tovar-Bazaga M; Blanco-García A; García-Cañete J; Parrón R; Esteban J
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884176
[TBL] [Abstract][Full Text] [Related]
11. Debridement and implant retention in the management of hip periprosthetic joint infection: outcomes following guided and rapid treatment at a single centre.
Sendi P; Lötscher PO; Kessler B; Graber P; Zimmerli W; Clauss M
Bone Joint J; 2017 Mar; 99-B(3):330-336. PubMed ID: 28249972
[TBL] [Abstract][Full Text] [Related]
12. Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection.
Zhang CF; He L; Fang XY; Huang ZD; Bai GC; Li WB; Zhang WM
Orthop Surg; 2020 Apr; 12(2):463-470. PubMed ID: 32159296
[TBL] [Abstract][Full Text] [Related]
13. Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years.
Westberg M; Grøgaard B; Snorrason F
Acta Orthop; 2012 Jun; 83(3):227-32. PubMed ID: 22489892
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention.
Wouthuyzen-Bakker M; Sebillotte M; Lomas J; Taylor A; Palomares EB; Murillo O; Parvizi J; Shohat N; Reinoso JC; Sánchez RE; Fernandez-Sampedro M; Senneville E; Huotari K; Barbero JM; Garcia-Cañete J; Lora-Tamayo J; Ferrari MC; Vaznaisiene D; Yusuf E; Aboltins C; Trebse R; Salles MJ; Benito N; Vila A; Toro MDD; Kramer TS; Petersdorf S; Diaz-Brito V; Tufan ZK; Sanchez M; Arvieux C; Soriano A;
J Infect; 2019 Jan; 78(1):40-47. PubMed ID: 30092305
[TBL] [Abstract][Full Text] [Related]
15. Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics: functional outcomes, quality of life and complications.
Aboltins C; Dowsey MM; Peel T; Lim WK; Parikh S; Stanley P; Choong PF
Intern Med J; 2013 Jul; 43(7):810-5. PubMed ID: 23656615
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Debridement, Antibiotics, and Implant Retention for Staphylococcal Hip and Knee Prosthetic Joint Infections, Focused on Rifampicin Use: A Systematic Review and Meta-Analysis.
Scheper H; Gerritsen LM; Pijls BG; Van Asten SA; Visser LG; De Boer MGJ
Open Forum Infect Dis; 2021 Jul; 8(7):ofab298. PubMed ID: 34258321
[TBL] [Abstract][Full Text] [Related]
17. Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant.
Gómez J; Canovas E; Baños V; Martínez L; García E; Hernández-Torres A; Canteras M; Ruiz J; Medina M; Martínez P; Canovas A; Soriano A; Clavel M
Antimicrob Agents Chemother; 2011 Sep; 55(9):4308-10. PubMed ID: 21690277
[TBL] [Abstract][Full Text] [Related]
18. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
Aboltins CA; Page MA; Buising KL; Jenney AW; Daffy JR; Choong PF; Stanley PA
Clin Microbiol Infect; 2007 Jun; 13(6):586-91. PubMed ID: 17331125
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks.
Chaussade H; Uçkay I; Vuagnat A; Druon J; Gras G; Rosset P; Lipsky BA; Bernard L
Int J Infect Dis; 2017 Oct; 63():37-42. PubMed ID: 28804007
[TBL] [Abstract][Full Text] [Related]
20. Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.
Kramer TS; Soriano A; Tedeschi S; Chen AF; Tattevin P; Senneville E; Gomez-Junyent J; Birlutiu V; Petersdorf S; de Brito VD; Gonzalez IS; Belden KA; Wouthuyzen-Bakker M
Open Forum Infect Dis; 2023 Oct; 10(10):ofad491. PubMed ID: 37901121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
